Glutathione transferase protects neuronal cultures against four hydroxynonenal toxicity

Free Radical Biology and Medicine

Volumn 25, Issue 8, 1998, Pages 979-988

  Xie, Chengsong ^a   Lovell, Mark A ^a,b   Markesbery, William R ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

4 Hydroxynonenal (HNE); Alzheimer's disease (AD); Glutathione transferase (GST); Neuronal culture; Protection

Indexed keywords

4 HYDROXYNONENAL; GLUTATHIONE; GLUTATHIONE TRANSFERASE;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL PROTECTION; CELL SURVIVAL; EMBRYO; HIPPOCAMPUS; LIPID PEROXIDATION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

4-CHLORO-7-NITROBENZOFURAZAN; ALDEHYDES; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; EMBRYO; GLUTATHIONE; GLUTATHIONE TRANSFERASE; HEAT; HIPPOCAMPUS; NEURONS; OXIDATION-REDUCTION; RATS;

ANIMALIA;

EID: 0032533744     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(98)00186-5     Document Type: Article

References (54)

1. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23:1997;134-147.
2. Lovell M.A., Ehmann W.D., Butler S.M., Markesbery W.R. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology. 45:1995;1594-1601.
3. Hensley K., Hall N., Subramanian R., Cole P., Harris M., Aksenov M., Aksenova M., Gabbita S.P., Wu J.F., Carney J.M., Markesbery W.R., Butterfield D.A. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 65:1995;2146-2156.
4. Smith D.C., Carney J.M., Starke-Reed P.E., Oliver C.N., Stadtman E.R., Floyd R.A., Markesbery W.R. Excess brain protein oxidation and enzyme dysfunction in normal aging and Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 88:1991;10540-10543.
5. Mecocci P., MacGarvey U., Beal M.F. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36:1994;747-751.
6. Gabbita, S. P.; Lovell, M. A.; Markesbery, W. R. Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J. Neurochem. in press; 1998.
7. Prasad M.R., Lovell M.A., Yatin M., Dhillon H., Markesbery W.R. Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem. Res. 23:1998;81-88.
8. Svennerholm L., Gottfries C.G. Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type II) and demyelination in late-onset form (type II). J. Neurochem. 62:1994;1039-1047.
9. Good P.F., Werner P., Hsu A., Olanow C.W., Perl D.P. Evidence for neuronal oxidative damage in Alzheimer's disease. Am. J. Pathol. 149:1996;21-28.
10. Smith M.A., Taneda S., Richey P.L., Miyata S., Yan S.-D., Stern D., Sayre L.M., Monnier V.M., Perry G. Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc. Natl. Acad. Sci. USA. 91:1994;5710-5714.
11. Smith M.A., Perry G., Richey P.L., Sayre L.M., Anderson V.E., Beal M.F., Kowall N. Oxidative damage in Alzheimer's disease. Nature. 382:1996;120-121.
12. Yan S.D., Chen X., Schmidt A.-M., Brett J., Goodman G., Zou Y.S., Scott C.W., Caputo C., Frappier T., Smith M.A., Perry G., Yen S.H., Stern D. Glycated tau protein in Alzheimer's disease a mechanism for induction of oxidant stress . Proc. Natl. Acad. Sci. USA. 91:1994;7787-7791.
13. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11:1991;81-128.
14. Blanc E.M., Kelley J.F., Mark R.J., Waeg G., Mattson M.P. 4-Hydroxynonenal, an aldehydic product of lipid peroxidation, impairs signal transduction associated with muscarinic acetylcholine and metabotropic glutamate receptors: possible action on G alpha (g/11). J. Neurochem. 69:1997;570-580.
15. Kruman I., Bruce-Keller A.J., Bredesen D., Waeg G., Mattson M.P. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17:1997;5089-5100.
16. Mark R.J., Lovell M.A., Markesbery W.R., Uchida K., Mattson M.P. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem. 68:1997;255-264.
17. Lovell M.A., Ehmann W.D., Mattson M.P., Markesbery W.R. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol. Aging. 18:1997;457-461.
18. Markesbery W.R., Lovell M.A. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging. 19:1998;33-36.
19. Mannervik B., Danielson U.H. Glutathione transferases - Structure and catalytic activity. CRC Crit. Rev. Biochem. 22:1988;283-337.
20. Warholm M., Guthenberg C., Mannervik B., von Bahr C., Glaumann H. Identification of a new glutathione S-transferase in human liver. Acta Chem. Scand. B. 34:1980;607-610.
21. Warholm M., Guthenberg C., Mannervik B., von Hahr C. Purification of a new glutathione S-transferase (transferase mu) from human liver having high activity with benzo (a) pyrene-4,5-oxide. Biochem. Biophys. Res. Commun. 98:1981;512-519.
22. Mannervik B., Guthenberg C., Jensson H., Warholm M., Alin P. Isozymes of gluatathione s-transferase in rat and human tissues. Larsson A., Orrenius S., Holmgren A., Mannervik B. Functions of glutathione Biochemical, pharmacological, toxicological and clinical aspects . 1983;75-88 Raven Press, New York.
23. Marcus C.J., Habig W.H., Jacoby W.B. Glutathione transferase from human erythrocytes, nonidentity with the enzymes from liver. Arch. Biochem. Biophys. 188:1978;287-293.
24. Guthenberg C., Akerfeldt K., Mannervik B. Purification of glutathione S-transferase from human placenta. Acta Chem. Scand. B33:1979;595-596.
25. Lovell, M. A.; Xie, C. S.; Markesbery, W. R. Glutathione transferase activity is decreased in brain and ventricular fluid in Alzheimer's disease. Neurology. in press.
26. Mattson M.P., Barger S.W., Begley J.G., Mark R.J. Calcium, free radicals and excitotoxic neuronal death in primary cell culture. Methods Cell Biol. 46:1995;187-216.
27. Mosmann T. Rapid colorimetric assay for cellular growth and survival. J. Immunol. Methods. 65:1983;55-63.
28. Musser D.A., Oseroff A.R. The use of tetrazolium salts to determine sites of damage to the mitochondrial electron transport chain in intact cells following in vitro photodynamic therapy with Photofrin II. Photochem Photobiol. 59:1994;621-626.
29. Ricci G., Cacurri A.M., Lo Bello M., Pastore A., Piemonte F., Federici G. Colorimetric and fluorometric assays of glutathione transferase based on 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole. Anal. Biochem. 218:1994;463-465.
30. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione. Applications to mammalian blood and other tissues. Anal. Biochem. 27:1969;502-522.
31. Eyer P., Podhradsky D. Evaluation of the micromethod for determination of glutathione using enzymatic cycling and Ellman's reagent. Anal. Biochem. 153:1986;57-66.
32. Griffith O.W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106:1980;207-212.
33. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab Clin. Med. 70:1967;158-169.
34. Mizuno Y., Ohta K. Regional distributions of thiobarbituric acid-reactive products, activities of enzymes regulating the metabolism of oxygen free radicals, and some of the related enzymes in adult and aged rat brains. J. Neurochem. 46:1986;1344-1352.
35. Jurgens G., Lang J., Esterbauer H. Modification of human low-density lipoprotein by the lipid peroxidation product 4-hydroxynonenal. Biochim. Biophys. Acta. 875:1986;103-114.
36. Uchida K., Stadtman E.R. Modification of histidine residues in proteins by reaction with 4-hydroxynonenal. Proc. Natl. Acad. Sci. USA. 89:1992;4544-4548.
37. Montine K.S., Kim P.J., Olson S.J., Markesbery W.R., Montine T.J. 4-hydroxy-2-nonenal pyrrole adducts in human degenerative disease. J. Neuropathol. Exp. Neurol. 56:1997;866-871.
38. Montine, K. S.; Reich, E.; Neely, D.; Sidell, K.; Olson, S. J.; Markesbery, W. R.; Montine, T. J. Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer's disease is associated with APOE genotype. J. Neuropathol. Exp. Neurol. in press.
39. Sayre L.M., Zelasko D.A., Harris P.L.R., Perry G., Salomon R.G., Smith M.A. 4-hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 68:1997;2092-2097.
40. Mark R.J., Pang Z., Geddes J.W., Uchida K., Mattson M.P. Amyloid β-peptide impairs glucose transport in hippocampal and cortical neurons Involvement of membrane lipid peroxidation . J. Neurosci. 17:1997;1046-1054.
41. Keller J.N., Pang Z., Geddes J.W., Begley J.G., Germeyer A., Waeg G., Mattson M.P. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide role of the lipid peroxidation product, 4-hydroxynonenal . J. Neurochem. 69:1997;273-284.
42. Lovell, M. A.; Xie, C. S.; Markesbery, W. R. 4-Hydroxynonenal impairs choline acetyltransferase. Neurobiol. Aging. Submitted.
43. Widersten M., Bjornestedt R., Mannervik B. Contribution of amino acid residue 208 in the hydrophobic binding site to the catalytic mechanism of human glutathione transferase A1-1. Biochemistry. 33:1994;11717-11723.
44. Morgenstern R., Lundquist G., Mosialou E., Andersson C. Hayes J.D., Pickett C.B., Mantle T.J. Glutathione S-transferases and drug resistance. 1990;57-64 Taylor and Francis, London.
45. Ketterer B., Tan K.H., Meyer D.J., Coles B. Glutathione transferases A possible role in the detoxification of DNA and lipid hydroperoxides . Mantle R., Pickett C., Hayes J. Glutathione S-transferases and carcinogenesis. 1987;Taylor and Francis, London.
46. Spearman M.E., Prough R.A., Estabrook R.W., Falck J.R., Manna S., Leibman K.C., Murphy R.C., Capdevial J. Novel glutathione conjugates formed from epoxyeicosatrienoic acids (EETS). Arch. Biochem. Biophys. 242:1985;225-230.
47. Watabe T., Sawahata T., Horie J. Evidence for the formation of a steroid S-glutathione conjugate from an epoxysteroid precursor. Biochem. Biophys. Res. Commun. 87:1979;469-475.
48. Meyer D.J., Ketterer B. 5 Alpha, 6 alpha-epoxy-cholestan-3 beta-ol (cholesterol alpha oxide): a specific substrate for rat liver, glutathione transferase B. FEBS Lett. 150:1982;499-502.
49. Jensson H., Guthenberg C., Alin P., Mannervik B. Rat glutathione transferase 8-8, an enzyme efficiently detoxifying 4-hydroxyalk-2-enals. FEBS Lett. 203:1986;207-209.
50. Alin P., Danielson U.H., Mannervik B. 4-hydroxyalk-2-enals are substrates for glutathione transferase. FEBS Lett. 179:1985;267-270.
51. Ishikawa T., Esterbauer H., Sies H. Role of cardiac glutathione transferase and of the glutathione S-conjugate export system in biotransformation of 4-hydroxynonenal in the heart. J. Biol. Chem. 261:1986;1576-1581.
52. Danielson U.H., Esterbauer H., Mannervik B. Structure activity relationships of 4-hydroxyalkenals in the conjugation catalyzed by mammalian glutathione transferases. Biochem. J. 247:1987;707-713.
53. Fahey R.C. Biologically important thiol-disulfhide reactions and the role of cyst(e)ine in proteins an evolutionary perspective . Adv. Exp. Med. Biol. 86A:1977;1-30.
54. Zimniak L., Awasthi S., Srivastava S.K., Zimniak P. Increased resistance to oxidative stress in transfected cultured cells overexpressing glutathione s-transferase mGSTA4-4. Toxicol. Appl. Pharmacol. 143:1997;221-229.